Mahlen SD. Serratia infections: from military experiments to current practice. Clin Microbiol Rev. 2011;24(4):755–91.
Gonzalez-Juarbe N, Mares CA, Hinojosa CA, Medina JL, Cantwell A, Dube PH, Orihuela CJ, Bergman MA. Requirement for Serratia marcescens cytolysin in a murine model of hemorrhagic pneumonia. Infect Immun. 2015;83(2):614–24.
Bukhari SZ, Banjar A, Baghdadi SS, Baltow BA, Ashshi AM, Hussain WM. Central line associated blood stream infection rate after intervention and comparing outcome with national healthcare safety network and international nosocomial infection control consortium data. Ann Med Health Sci Res. 2014;4(5):682–6.
Larson EL, Cimiotti JP, Haas J, Nesin M, Allen A, Della-Latta P, Saiman L. Gram-negative bacilli associated with catheter-associated and non-catheter-associated bloodstream infections and hand carriage by healthcare workers in neonatal intensive care units. Pediatr Crit Care Med. 2005;6(4):457–61.
Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S, National Healthcare Safety Network, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol. 2013;34(1):1–14.
Apostolopoulou E, Zikos D, Tselebis A, Drosatou X, Stefanidis E, Xristodoulou A, Katsaris G. Clinical outcomes and economic variables in critically ill patients with bloodstream infections. Health Sci J. 2014;8(4):519–30.
Satpathy S, Sen SK, Pattanaik S, Raut S. Review on bacterial biofilm: an universal cause of contamination. Biocatal Agric Biotechnol. 2016;7:56–66.
Flemming H-C, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S. Biofilms: an emergent form of bacterial life. Nat Rev Micro. 2016;14(9):563–75.
Nandre RM, Chaudhari AA, Matsuda K, Lee JH. Immunogenicity of a Salmonella enteritidis mutant as vaccine candidate and its protective efficacy against salmonellosis in chickens. Vet Immunol Immunopathol. 2011;144(3–4):299–311.
Nandre RM, Matsuda K, Chaudhari AA, Kim B, Lee JH. A genetically engineered derivative of Salmonella enteritidis as a novel live vaccine candidate for salmonellosis in chickens. Res Vet Sci. 2012;93(2):596–603.
Srinivasan R, Devi KR, Kannappan A, Pandian SK, Ravi AV. Piper betle and its bioactive metabolite phytol mitigates quorum sensing mediated virulence factors and biofilm of nosocomial pathogen Serratia marcescens in vitro. J Ethnopharmacol. 2016;193:592–603.
Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis. 2001;33(8):1387–92.
Justo JA, Bookstaver PB. Antibiotic lock therapy: review of technique and logistical challenges. Infect Drug Resist. 2014;7:343–63.
Snaterse M, Rüger W, Scholte op Reimer WJM, Lucas C. Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect. 2010;75(1):1–11.
Coors EA, Seybold H, Merk HF, Mahler V. Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. Ann Allergy Asthma Immunol. 2005;95(6):593–9.
Malinowski AM, McClarty BM, Robinson C, Spear W, Sanchez M, Sparkes TC, Brooke JS. Polysorbate 80 and polymyxin B inhibit Stenotrophomonas maltophilia biofilm. Diagn Microbiol Infect Dis. 2017;87(2):154–6.
Sloup RE, Cieza RJ, Needle DB, Abramovitch RB, Torres AG, Waters CM. Polysorbates prevent biofilm formation and pathogenesis of Escherichia coli O104:H4. Biofouling. 2016;32(9):1131–40.
Chen H, Gao Y, Wang A, Zhou X, Zheng Y, Zhou J. Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents. Eur J Med Chem. 2015;92:648–55.
Zhou L, Ding Y, Chen W, Zhang P, Chen Y, Lv X. The in vitro study of ursolic acid and oleanolic acid inhibiting cariogenic microorganisms as well as biofilm. Oral Dis. 2013;19(5):494–500.
Gonzalez-Juarbe N, Gilley RP, Hinojosa CA, Bradley KM, Kamei A, Gao G, Dube PH, Bergman MA, Orihuela CJ. Pore-forming toxins induce macrophage necroptosis during acute bacterial pneumonia. PLoS Pathog. 2015;11(12):e1005337.
Iwanaga M, Toma C, Miyazato T, Insisiengmay S, Nakasone N, Ehara M. Antibiotic resistance conferred by a class I integron and SXT constin in Vibrio cholerae O1 strains isolated in Laos. Antimicrob Agents Chemother. 2004;48(7):2364–9.
Carpenter J, Stapleton S, Holliman R. Brain Abscess. Eur J Clin Microbiol Infec Dis. 2007;26:1–11.
Howard J. Chloramphenicol—A review. Pediatr Rev. 2004;25:284–8.
Rehman Au, Rehman T, Ali R. Multi-antibiotic resistant brain abscess sensitive only to chloramphenicol: a case report. Cases J. 2009;2(1):6352.
O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39(4 Suppl 1):S1–34.
Matsumura N, Minami S, Mitsuhashi S. Sequences of homologous β-lactamases from clinical isolates of Serratia marcescens with different substrate specificities. Antimicrob Agents Chemother. 1998;42(1):176–9.
Livermore DM. Beta-lactamase-mediated resistance and opportunities for its control. J Antimicrob Chemother. 1998;41(Suppl 4):25–41.
Quinn GA, Maloy AP, Banat MM, Banat IM. A comparison of effects of broad-spectrum antibiotics and biosurfactants on established bacterial biofilms. Curr Microbiol. 2013;67(5):614–23.